Drug Type TCR therapy |
Synonyms- |
Target |
Mechanism PRAME modulators(PRAME nuclear receptor transcriptional regulator modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Zelluna Immunotherapy ASStartup |
Active Organization Zelluna Immunotherapy ASStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | NO | Zelluna Immunotherapy ASStartup | 01 Dec 2024 |